References
- Lindsley CB, Guillermo Russo RA. Managing Children with Rheumatic Diseases. In: Petty R, Laxer R, and Lindsley C, et al, editors. Textbook of Pedia Rheum. 7th ed. Philadelphia: Elsevier; 2016. p. 129–139e3. doi:10.1016/B978-0-323-24145-8.00011-9.
- Swart J, Giancane G, Horneff G, et al. Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from pharmachild and national registries. Arthritis Res Ther. 2018;20(1):1–11. doi: 10.1186/s13075-018-1780-z
- Esposito S, Prada E, Lelii M, et al. Immunization of children with secondary immunodeficiency. Human Vaccines Immunother. 2015;11(11):2564–2570. doi: 10.1080/21645515.2015.1039208
- Beukelman T, Xie F, Baddley JW, et al. Brief report: incidence of selected opportunistic infections among children with juvenile idiopathic arthritis. Arthritis & Rheumatism. 2013;65(5):1384–1389. doi: 10.1002/art.37866
- Higgins GCJPC. Complications of treatments for pediatric rheumatic diseases. Pediatr Clin North Am. 2018;65(4):827–854. doi: 10.1016/j.pcl.2018.04.008
- Becker I, Horneff G. research. Risk of serious infection in juvenile idiopathic arthritis patients associated with tumor necrosis factor inhibitors and disease activity in the German biologics in pediatric rheumatology registry. Arthritis Care Res. 2017;69(4):552–560. doi: 10.1002/acr.22961
- Glück T, Müller-Ladner UJCID. Vaccination in patients with chronic rheumatic or autoimmune diseases. Clinl Infect Dis. 2008;46(9):1459–1465. doi: 10.1086/587063
- Bloom DE, Canning D, Weston M. The value of vaccination. In: Stevens P, editor. Fighting the diseases of poverty. New York: Routledge; 2008. p. 214–238.
- Rémy V, Zöllner Y, Heckmann U, et al. Vaccination: the cornerstone of an efficient healthcare system. J Mark Access Health Policy. 2015;3(1):27041. doi: 10.3402/jmahp.v3.27041
- Morin M-P, Quach C, Fortin E, et al. Vaccination coverage in children with juvenile idiopathic arthritis followed at a paediatric tertiary care centre. Rheumatology. 2012;51(11):2046–2050. doi: 10.1093/rheumatology/kes175
- Minden K, Niewerth M, Borte M, et al. Immunization in children and adolescents with rheumatic diseases. Zeitschrift für Rheumatologie. 2007;66(2):111–2, 114. doi: 10.1007/s00393-007-0150-z
- Eskiocak M, Marangoz B. Türkiye’de Bağışıklama Hizmetlerinin Durumu. 2018 [cited 2022 Dec 15]. Available from: file:///C:/Users/drozl/Downloads/Documents/turkiyede_bagisiklama_hizmetlerinin_durumu.pdf
- Uziel Y, Moshe V, Onozo B, et al. Live attenuated MMR/V booster vaccines in children with rheumatic diseases on immunosuppressive therapy are safe: multicenter, retrospective data collection. Vaccine. 2020;38(9):2198–2201. doi: 10.1016/j.vaccine.2020.01.037
- Çakmak F, Akgün Ö, Demirkan FG, et al. Live attenuated measles, mumps and rubella booster vaccine in children diagnosed with rheumatic disease: a single-center study. Eur J Pediatr. 2022;182(1):135–140. doi: 10.1007/s00431-022-04646-x
- Jansen MH, Rondaan C, Legger GE, et al. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheumatic Dis. 2022;82(1):35–47. doi: 10.1136/annrheumdis-2022-222574
- Rollet-Cohen V, Mirete J, Dingulu G, et al. Suboptimal vaccination coverage of recommended vaccines among French children with recurrent autoinflammatory fever syndromes: a study from the juvenile inflammatory rheumatism cohort. Clin Rheumatol. 2021;40(7):2855–2864. doi: 10.1007/s10067-020-05553-y
- Balažiová B, Kuková Z, Mišíková D, et al. Real-life vaccination coverage in Slovak children with rheumatic diseases. Front Pediatr. 2022;10:10. doi: 10.3389/fped.2022.956136
- Welzel T, Kuemmerle-Deschner J, Sluka C, et al. Vaccination completeness in children with rheumatic diseases: a longitudinal, observational multicenter cohort study in Switzerland. Front Pediatr. 2022;10:1481. doi: 10.3389/fped.2022.993811
- 2022 ECfDPaCE. Vaccine schedules in all countries in the EU/EEA. 2022 [cited 2022 Jun 12]. Available from: https://vaccine-schedule.ecdc.europa.eu/
- Kostik MM, Lubimova NA, Fridman IV, et al. The vaccine coverage and vaccine immunity status and risk factors of non-protective levels of antibodies against vaccines in children with juvenile idiopathic arthritis: cross-sectional Russian tertiary centre study. Pediatr Rheumatol. 2021;19(1):1–10. doi: 10.1186/s12969-021-00594-2
- Ozen S, Kuemmerle‐Deschner JB, Cimaz R, et al. International retrospective chart review of treatment patterns in severe familial Mediterranean fever, tumor necrosis factor receptor–associated periodic syndrome, and mevalonate kinase deficiency/hyperimmunoglobulinemia D syndrome. Arthritis Care Res. 2017;69(4):578–586. doi: 10.1002/acr.23120
- Bizjak M, Blazina Š, Markelj G, et al. Vaccination coverage in children with rheumatic diseases. Clin Exp Rheumatol. 2019;38(1):164–170.
- Lima Melo JM, Pileggi GC, Martins De CarvalhoL, et al. Immunization status of children with rheumatic diseases: can the pediatric rheumatologist help to improve? (abstract) pediatric rheumatology In European society congress. 2010.
- Chehab G, Richter JG, Brinks R, et al. Vaccination coverage in systemic lupus erythematosus—a cross-sectional analysis of the German long-term study (LuLa cohort). Rheumatology. 2018;57(8):1439–1447. doi: 10.1093/rheumatology/key120